1,080 material Form 8-K filings that 839 companies we cover made with the SEC in May 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
KBR reported first quarter fiscal 2025 results with revenues of $2.1 billion, up 13%, and net income attributable to KBR of $116 million, up 25% from the prior year period. The company reaffirmed its fiscal 2025 outlook and repurchased $156 million of its stock during the quarter, which lowered the diluted share count.
Revenues of $2,055 million vs. $1,818 million a year earlier, up 13%
Net income attributable to KBR of $116 million vs. $93 million; diluted EPS of $0.88 vs. $0.69
Adjusted EPS of $0.98, up 27%; Adjusted EBITDA of $243 million, up 17%
Fiscal 2025 guidance reaffirmed: revenues $8.7 billion to $9.1 billion, Adjusted EPS $3.71 to $3.95
Louisiana-Pacific reported first-quarter 2025 results with net sales flat at $724 million, while net income fell $17 million to $91 million and diluted earnings per share fell to $1.30 from $1.48. Higher Siding sales were offset by lower OSB prices and volumes, and the company issued second-quarter and full-year 2025 guidance. The company also declared a $0.28 per share quarterly dividend.
Net sales flat at $724 million; Siding up $41 million to $402 million, OSB down $46 million to $267 million
Net income $91 million, down $17 million; Adjusted EBITDA $162 million, down $20 million
Guidance: second-quarter consolidated Adjusted EBITDA of $125 million to $145 million; full-year $535 million to $555 million
Quarterly dividend of $0.28 per share, payable June 3, 2025, to holders of record as of May 20, 2025
NW Natural Holdings reported first-quarter 2025 net income of $87.9 million ($2.18 per share), up from $63.8 million ($1.69 per share) a year earlier, and adjusted EPS of $2.28 after SiEnergy transaction costs. The company reaffirmed its 2025 adjusted EPS guidance of $2.75 to $2.95 and agreed to buy Hughes Gas Resources for $60 million, which it expects to close in the second quarter of 2025.
Q1 2025 net income $87.9 million ($2.18 per share) vs. $63.8 million ($1.69 per share) in Q1 2024; adjusted EPS $2.28
Operating revenues $494.3 million vs. $433.5 million in Q1 2024
2025 adjusted EPS guidance of $2.75 to $2.95 reaffirmed; GAAP EPS guidance lowered to $2.65 to $2.85 from $2.66 to $2.86 due to Hughes transaction costs
Agreed to acquire Hughes Gas Resources from EPCOR USA for $60 million; expected to close in Q2 2025
Leidos reported first-quarter fiscal 2025 revenue of $4.25 billion, up 7%, and net income of $365 million, or $2.77 per diluted share, up 34% from $2.07 a year earlier. The company reaffirmed its full-year 2025 guidance, including revenue of $16.90 billion to $17.30 billion and non-GAAP diluted EPS of $10.35 to $10.75, while operating cash flow fell to $58 million from $113 million.
Revenue $4.25 billion, up 7%; net income $365 million, up 29%; GAAP diluted EPS $2.77 versus $2.07
Non-GAAP diluted EPS $2.97, up 30%; adjusted EBITDA $601 million, a 14.2% margin
Operating cash flow $58 million versus $113 million a year earlier; free cash flow $36 million
Backlog recast under a new policy to $46.3 billion; company also disclosed a pending $300 million cyber acquisition and a $500 million accelerated share repurchase
Archrock reported first-quarter 2025 revenue of $347.2 million, up from $268.5 million a year earlier, and net income of $70.9 million, or $0.40 per share, compared with $40.5 million, or $0.26 per share, in the first quarter of 2024. The company raised its full-year 2025 adjusted EBITDA guidance to $790 million to $830 million and increased its share repurchase program by $50 million, which signals higher expected earnings and continued capital returns to shareholders.
Q1 2025 adjusted EBITDA was $197.8 million, compared with $131.0 million in Q1 2024.
Full-year 2025 adjusted EBITDA guidance was raised to $790 million to $830 million.
The NGCS acquisition closed on May 1, 2025, and the Board approved an additional $50 million for the share repurchase program, with $65.2 million of capacity as of May 1, 2025.
Duke Energy reported first-quarter 2025 reported and adjusted EPS of $1.76, up from $1.44 in the first quarter of 2024, with total operating revenues of $8,249 million compared with $7,671 million a year earlier. The company reaffirmed its 2025 adjusted EPS guidance range of $6.17 to $6.42, which matters to shareholders because it indicates management expects results to stay within that range for the full year.
Q1 2025 reported and adjusted EPS of $1.76, versus $1.44 in Q1 2024, with no special items in either period
Electric Utilities and Infrastructure segment income rose to $1,276 million from $1,021 million; Gas segment income rose to $349 million from $284 million
2025 adjusted EPS guidance of $6.17 to $6.42 reaffirmed; long-term adjusted EPS growth target of 5% to 7% through 2029
Cabot reported fiscal second-quarter 2025 results for the period ended March 31, 2025. Adjusted EPS rose 7% year over year to $1.90 and diluted EPS was $1.69, but net sales fell to $936 million from $1,019 million, and the company revised its fiscal 2025 Adjusted EPS guidance to $7.15 to $7.50, citing expected lower customer demand in the second half.
Diluted EPS was $1.69 versus $1.49 a year earlier; Adjusted EPS was $1.90 versus $1.78.
Reinforcement Materials segment EBIT fell 12% to $131 million, while Performance Chemicals EBIT rose 61% to $50 million.
Fiscal 2025 Adjusted EPS guidance was revised to $7.15 to $7.50, and the quarterly dividend was raised 5% to $0.45 per share.
Celanese reported first quarter 2025 results on May 5, 2025, with net sales of $2.4 billion, down from $2.6 billion a year earlier, and a U.S. GAAP diluted loss per share of $0.15 versus earnings of $1.10 in the prior-year quarter. The company guided to second quarter adjusted EPS of $1.30 to $1.50 and expects 2025 free cash flow of $700 to $800 million, while also announcing an intention to fully divest the Micromax business.
Q1 2025 net sales $2.4 billion (versus $2.6 billion in Q1 2024); operating profit $168 million (versus $210 million); free cash flow negative $73 million
Adjusted EPS $0.57 versus $2.08 in Q1 2024; U.S. GAAP diluted loss per share $0.15 versus $1.10 earnings
Q2 2025 adjusted EPS guidance of $1.30 to $1.50; 2025 free cash flow target of $700 million to $800 million
2025 cost reduction target raised to approximately $120 million; intention to divest Micromax announced
Kilroy Realty reported first-quarter 2025 results below the same quarter a year earlier, with revenues of $270.8 million versus $278.6 million and net income available to common stockholders of $39.0 million, or $0.33 per diluted share, versus $49.9 million, or $0.42. The company affirmed its full-year 2025 FFO guidance of $3.85 to $4.05 per diluted share and agreed to sell part of its Santa Fe Summit land in San Diego for $38.0 million, a sale expected to close after entitlements are received, which the company expects in 2026.
Revenues of $270.8 million for Q1 2025 versus $278.6 million for Q1 2024
Net income available to common stockholders of $39.0 million ($0.33 per diluted share) versus $49.9 million ($0.42) a year earlier
FFO of $122.3 million ($1.02 per diluted share) versus $133.7 million ($1.11); full-year 2025 FFO guidance of $3.85 to $4.05 affirmed
Agreement to sell about five acres of the Santa Fe Summit site for $38.0 million in gross proceeds, with closing expected upon entitlements in 2026
Addus HomeCare reported first quarter 2025 results for the period ended March 31, 2025, with net service revenues up 20.3% year over year to $337.7 million and net income of $21.2 million, or $1.16 per diluted share, versus $0.97 a year earlier. Results include the first full quarter of the Gentiva personal care operations, acquired December 2, 2024, and the filing does not include any change to guidance.
Net service revenues were $337.7 million, up from $280.7 million in the first quarter of 2024.
Net income was $21.2 million, or $1.16 per diluted share, compared with $15.8 million, or $0.97 per diluted share.
Adjusted net income per diluted share rose 17.4% to $1.42; adjusted EBITDA rose 25.1% to $40.6 million.
Cash at March 31, 2025 was $97.0 million and bank debt was $203.0 million.
Interparfums reported first-quarter 2025 net sales of $339 million, up 5%, and diluted earnings per share of $1.32, up 4% from $1.27 a year earlier. The company reaffirmed its 2025 guidance of $1.51 billion in net sales and $5.35 in diluted EPS, both up 4%, which signals management expects the year to track its original plan.
Operating income rose 10% to $75 million, and operating margin widened to 22.2% from 21.0%.
Gross margin improved to 63.7% from 62.5%, which the company attributed to favorable brand and channel mix.
Cash used in operating activities fell to $7 million from $52 million a year earlier.
The quarterly dividend is $0.80 per share, payable June 30, 2025, to shareholders of record on June 13, 2025.
Primoris reported first-quarter 2025 revenue of $1.6 billion, up 16.7% from a year earlier, with net income of $44.2 million, or $0.81 per diluted share, versus $0.35 a year earlier. The company maintained its full-year 2025 outlook and authorized a share purchase program of up to $150 million through April 30, 2028. The filing also covers board appointments, shareholder votes, and a quarterly dividend of $0.08 per share.
Q1 2025 revenue of $1,648.1 million, up $235.4 million, or 16.7%, led by the Energy and Utilities segments
Net income of $44.2 million, or $0.81 per diluted share, versus $18.9 million, or $0.35 per share, in Q1 2024
Full-year 2025 EPS outlook of $3.70 to $3.90 was maintained; the company did not change its guidance
Board authorized a share purchase program of up to $150 million, expiring April 30, 2028; dividend of $0.08 per share payable July 15, 2025
Tidewater reported first-quarter 2025 revenue of $333.4 million, up 3.8% from $321.2 million a year earlier, but net income fell to $42.7 million ($0.83 per share) from $47.0 million ($0.89 per share). The company reiterated its 2025 revenue guidance of $1.32 to $1.38 billion and gross margin guidance of 48% to 50%, and said it repurchased 2.3 million shares for $90.0 million through April 14, 2025.
Q1 2025 revenue of $333.4 million, up from $321.2 million in Q1 2024
Net income of $42.7 million ($0.83 per diluted share), down from $47.0 million ($0.89 per share)
Free cash flow of $94.7 million and net cash from operating activities of $86.0 million
2025 revenue guidance of $1.32 to $1.38 billion reiterated, not changed
Atlas Energy Solutions reported first quarter 2025 total sales of $297.6 million, up from $192.7 million a year earlier, while net income fell to $1.2 million from $26.8 million. Management said Q2 sales volumes and Adjusted EBITDA are expected to be relatively flat to up sequentially, and that some customers are deferring planned development projects.
Total sales were $297.6 million, up 9.7% from the fourth quarter of 2024 and up from $192.7 million in the first quarter of 2024.
Net income was $1.2 million, compared with $26.8 million a year earlier. SG&A included $8.2 million in acquisition-related and other transaction costs.
Adjusted EBITDA was $74.3 million, a 25% margin, compared with $75.5 million and a 39% margin in the first quarter of 2024.
Quarterly dividend of $0.25 per share was maintained, payable May 22, 2025 to holders of record on May 15, 2025.
BWX Technologies reported first quarter 2025 results on May 5, 2025, with revenue up 13% to $682.3 million and GAAP net income up 10% to $75.5 million. The company reaffirmed its 2025 non-GAAP EPS guidance of $3.40-$3.55 and said the pending Kinectrics acquisition remains on track to close in mid-2025.
Revenue of $682.3 million, up from $604.0 million a year earlier; Government Operations rose 14% and Commercial Operations rose 10%.
Diluted GAAP EPS of $0.82 versus $0.75; non-GAAP EPS of $0.91 versus $0.76.
Commercial Operations operating income fell 25% to $6.5 million; 2025 non-GAAP EPS guidance of $3.40-$3.55 was reaffirmed.
Certara reported first-quarter 2025 revenue of $106.0 million, up 10% from a year earlier, and net income of $4.7 million, compared with a net loss of $4.7 million in the prior-year quarter. The company reiterated its full-year 2025 guidance, including revenue of $415 million to $425 million, so shareholders have no new change to the outlook.
Revenue was $106.0 million, up 10% from $96.7 million in Q1 2024; software revenue rose 18% to $46.4 million.
Net income was $4.7 million, or $0.03 per diluted share, versus a net loss of $4.7 million in Q1 2024.
Adjusted EBITDA was $34.8 million, up 20% from $29.1 million.
Full-year 2025 guidance was reiterated: revenue of $415 million to $425 million and adjusted diluted EPS of $0.42 to $0.46.
Bright Horizons reported first-quarter 2025 revenue of $666 million, up 7%, and net income of $38 million, up 124%, with diluted earnings per share of $0.66 compared with $0.29. The company also updated its 2025 guidance to revenue of $2.865 billion to $2.915 billion and diluted adjusted earnings per share of $3.95 to $4.15. The filing does not state prior guidance, so the direction of the change cannot be determined from it.
Revenue of $666 million, up 7%; income from operations of $62 million, up 56%
Diluted EPS of $0.66 versus $0.29; diluted adjusted EPS of $0.77 versus $0.51
2025 revenue guidance of $2.865 billion to $2.915 billion; diluted adjusted EPS guidance of $3.95 to $4.15
Cash from operations of $86.2 million, compared with $116.3 million in the first quarter of 2024
Boise Cascade reported first quarter 2025 net income of $40.3 million, or $1.06 per diluted share, on sales of $1.5 billion, compared with $104.1 million, or $2.61 per share, on sales of $1.6 billion a year earlier. Lower sales prices and volumes in its wood products and distribution segments drove the decline, and the company said it expects modest engineered wood product price erosion in the second quarter. Shareholders also re-elected eleven directors and approved the 2025 Omnibus Incentive Plan at the May 1 annual meeting.
Net income $40.3 million ($1.06 per diluted share) vs. $104.1 million ($2.61) in first quarter 2024
Sales $1.5 billion, down 7%; Adjusted EBITDA $91.6 million, down 46%
Wood Products segment income $17.7 million, down 75%; Building Materials Distribution segment income $48.4 million, down 33%
Shareholders elected eleven directors and approved the 2025 Omnibus Incentive Plan at the May 1, 2025 meeting
Vornado Realty Trust reported first-quarter 2025 net income attributable to common shareholders of $86.8 million, or $0.43 per diluted share, compared with a loss of $9.0 million a year earlier. The gain was driven mainly by a $76.2 million net gain on the partial sale of 666 Fifth condominium to UNIQLO and a $17.2 million reversal of PENN 1 rent expense, so the profit swing includes one-time items. FFO as adjusted, a non-GAAP measure, rose to $126.2 million, or $0.63 per diluted share, from $108.8 million, or $0.55, a year earlier.
Net income attributable to common shareholders was $86.8 million ($0.43 per diluted share), versus a loss of $9.0 million ($0.05 per share) in Q1 2024.
FFO attributable to common shareholders plus assumed conversions, as adjusted, was $126.2 million ($0.63 per diluted share), up from $108.8 million ($0.55).
The 666 Fifth sale to UNIQLO produced a $76.2 million gain, and the PENN 1 ground rent reset led to a $17.2 million rent expense reversal, both in the first quarter.
Fabrinet reported results for its fiscal third quarter ended March 28, 2025, with revenue of $871.8 million, up from $731.5 million a year earlier, and GAAP net income of $81.3 million, up from $80.9 million. The company also issued fourth-quarter guidance of $860 million to $900 million in revenue and $2.32 to $2.47 in GAAP diluted EPS, and the quarter's free cash flow was $45.7 million compared with $87.3 million a year earlier.
Q3 revenue $871.8 million vs. $731.5 million in the prior-year quarter; the company said this was above its guidance range
GAAP diluted EPS $2.25 vs. $2.21; non-GAAP diluted EPS $2.52 vs. $2.39
Q4 fiscal 2025 guidance: revenue $860 million to $900 million; non-GAAP diluted EPS $2.55 to $2.70
Non-GAAP free cash flow $45.7 million vs. $87.3 million in the prior-year quarter
CRH reported first quarter 2025 results for the period ended March 31, 2025. Total revenues rose 3% to $6.8 billion, but the company posted a net loss of $98 million, compared with net income of $114 million a year earlier, as gains on prior-year divestitures did not recur. Adjusted EBITDA rose 11% to $495 million, and CRH reaffirmed its 2025 guidance, which matters to shareholders because the profit swing and the reaffirmed outlook both bear on expected full-year results.
Total revenues of $6.8 billion, up 3% from $6.5 billion in Q1 2024; net loss of $98 million versus net income of $114 million a year earlier.
Diluted loss per share of ($0.15), compared with diluted earnings per share of $0.16 in Q1 2024.
Adjusted EBITDA of $495 million, up 11%; Adjusted EBITDA margin of 7.3%, up from 6.8%.
2025 guidance reaffirmed: net income of $3.7 billion to $4.1 billion and Adjusted EBITDA of $7.3 billion to $7.7 billion. A $0.37 quarterly dividend was declared and a new $0.3 billion buyback tranche is to be completed no later than August
SiriusPoint reported first-quarter 2025 results for the period ended March 31, 2025. Net income available to common shareholders fell to $57.6 million from $90.8 million a year earlier, while total revenues rose to $727.3 million from $685.5 million, and diluted earnings per share were flat at $0.49. The company attributed the profit decline mainly to $67.9 million of catastrophe losses, primarily from the California wildfires.
Net income available to common shareholders was $57.6 million, versus $90.8 million a year earlier; diluted EPS was $0.49, flat year over year.
Core combined ratio rose to 95.4% from 91.4%, and Core income fell to $47.4 million from $62.4 million.
Catastrophe losses were $67.9 million, primarily from the California wildfires; the company cited a $59 million net impact from the wildfires.
Book value per diluted common share excluding AOCI was $15.15, up 3.5% in the quarter; AM Best and Fitch revised their outlook to Positive from Stable.
LTC Properties reported first-quarter 2025 results, with total revenues of $49.0 million, down from $51.4 million a year earlier, and net income available to common stockholders of $20.5 million, down from $24.1 million. The company also issued full-year 2025 guidance, including GAAP net income of $3.38 to $3.42 per share and diluted Core FFO of $2.65 to $2.69 per share, which shareholders can compare against future results.
Total revenues were $49.0 million versus $51.4 million, and net income available to common stockholders was $20.5 million versus $24.1 million, for the quarter ended March 31, 2025.
Diluted earnings per share were $0.45 versus $0.56; NAREIT diluted FFO per share was $0.65 versus $0.69; diluted Core FFO per share was $0.65 versus $0.64.
2025 full-year guidance: GAAP net income of $3.38 to $3.42 per share, diluted Core FFO of $2.65 to $2.69 per share, and diluted Core FAD of $2.78 to $2.82 per share.
After quarter end, 12 properties under Anthem's triple-net leases were transitioned into the new SHOP portfolio, with a combined gross book value of $176.1 million.
Ingevity reported first-quarter 2025 net sales of $284.0 million, down 17%, mainly due to repositioning of its Performance Chemicals segment. Net income was $20.5 million, or $0.56 per diluted share, compared with a net loss of $56.0 million a year earlier, and adjusted EBITDA rose 23% to $91.3 million. The company widened its full-year 2025 guidance to sales of $1.25 billion to $1.40 billion and adjusted EBITDA of $380 million to $415 million, citing lower auto production forecasts tied to trade tensions.
Q1 net sales were $284.0 million, down 17%, with Performance Chemicals sales down 35% to $95.0 million.
Net income was $20.5 million ($0.56 per diluted share) after $20.2 million in before-tax special charges; adjusted EPS was $0.99.
Adjusted EBITDA was $91.3 million, up 23%, with an adjusted EBITDA margin of 32.1%.
Full-year 2025 guidance: sales of $1.25 billion to $1.40 billion and adjusted EBITDA of $380 million to $415 million; no share repurchases were made in the quarter.
Clorox reported third-quarter fiscal 2025 net sales of $1.67 billion, down 8%, mainly from the VMS and Argentina divestitures, and adjusted EPS of $1.45, down 15%. The company updated its fiscal 2025 outlook to forecast net sales down 1% to flat, while keeping its adjusted EPS range at $6.95 to $7.35, and raised its GAAP diluted EPS range to $5.73 to $6.13.
Net sales fell 8% to $1.67 billion; organic sales declined 2% and organic volume was flat.
Diluted EPS was $1.50 versus a loss of $0.41 a year earlier, including cyberattack insurance recoveries; adjusted EPS was $1.45 versus $1.71.
Fiscal 2025 net sales are now expected to be down 1% to flat; organic sales growth is now expected at 4% to 5%.
Fiscal 2025 adjusted EPS range of $6.95 to $7.35 is unchanged; GAAP diluted EPS range rose to $5.73 to $6.13 from $5.52 to $5.92.
AECOM reported fiscal second-quarter 2025 results for the quarter ended March 31, 2025, with revenue down 4% to $3.77 billion while profit rose, including adjusted EPS of $1.25, up 20%. The company raised its fiscal 2025 adjusted EBITDA and adjusted EPS guidance for the second time this year, which signals higher expected earnings for shareholders.
Revenue was $3.77 billion, down 4%; net service revenue was $1.87 billion, up 4%
Net income attributable to AECOM from continuing operations was $154 million, up 38%; diluted EPS from continuing operations was $1.16 versus $0.81 a year earlier
Fiscal 2025 adjusted EBITDA guidance is $1,180 million to $1,210 million; adjusted EPS guidance is $5.10 to $5.20
Shareholders received more than $110 million through repurchases and dividends during the quarter
Hims & Hers reported first quarter 2025 revenue of $586.0 million, up 111% from a year earlier, and net income of $49.5 million, compared with $11.1 million. The company affirmed its full-year 2025 revenue guidance of $2.3 billion to $2.4 billion and raised its full-year Adjusted EBITDA guidance to $295 million to $335 million. Gross margin fell to 73% from 82%, and second-quarter revenue guidance of $530 million to $550 million was below the first-quarter result.
Q1 2025 revenue was $586.0 million, up 111% year over year; net income was $49.5 million versus $11.1 million; diluted EPS was $0.20 versus $0.05.
Adjusted EBITDA was $91.1 million in Q1 2025, compared with $32.3 million a year earlier.
Full-year 2025 Adjusted EBITDA guidance was raised to $295 million to $335 million; full-year revenue guidance of $2.3 billion to $2.4 billion was affirmed.
The company set 2030 targets of at least $6.5 billion in revenue and $1.3 billion in Adjusted EBITDA.
Lattice Semiconductor reported first-quarter 2025 results for the period ended March 29, 2025, with revenue of $120.1 million, up 2.3% from the prior quarter but down 14.7% from a year earlier. GAAP net income was $5.0 million, or $0.04 per diluted share, down from $14.8 million a year earlier, and the company guided second-quarter 2025 revenue to between $118.5 million and $128.5 million. Revenue rose sequentially, but profit and year-over-year sales declined, so the results point in different directions for shareholders.
GAAP net income was $5.0 million, or $0.04 per diluted share, versus $14.8 million, or $0.11 per diluted share, in Q1 2024.
Non-GAAP net income per diluted share was $0.22, compared with $0.29 in Q1 2024 and $0.15 in Q4 2024.
Q2 2025 outlook: revenue of $118.5 million to $128.5 million and non-GAAP net income of $0.22 to $0.26 per share.
Free cash flow was $23.3 million, and the company repurchased $25.0 million of common stock in the quarter.
Palomar Holdings reported first quarter 2025 net income of $42.9 million, or $1.57 per diluted share, up from $26.4 million, or $1.04, a year earlier. The company also raised its full-year 2025 adjusted net income outlook to $186 million to $200 million, from $180 million to $192 million, which is favorable for shareholders.
Net income was $42.9 million, or $1.57 per diluted share, versus $26.4 million, or $1.04, in Q1 2024
Adjusted net income rose 84.6% to $51.3 million; gross written premiums grew 20.1% to $442.2 million
Full-year 2025 adjusted net income outlook raised to $186 million to $200 million from $180 million to $192 million
Expenses associated with transactions were $2.1 million in the quarter, tied to the acquisition of Advanced AgProtection
Artivion reported first quarter 2025 revenue of $99.0 million, up 2% on a GAAP basis, but swung to a GAAP net loss of $0.5 million, or $(0.01) per share, from net income of $7.5 million a year earlier. The company raised the midpoint of its full year 2025 revenue guidance to $423 to $435 million, while its adjusted EBITDA outlook of $84 to $91 million was unchanged. The quarter was affected by the November 2024 cybersecurity incident, which reduced preservation services revenue by 23%.
Q1 2025 revenue was $99.0 million versus $97.4 million in Q1 2024, up 2% on a GAAP basis and 4% on a constant currency basis.
GAAP net loss was $(0.5) million, or $(0.01) per diluted share; non-GAAP net income was $2.5 million, or $0.06 per diluted share.
Adjusted EBITDA rose 1% to $17.5 million from $17.3 million a year earlier.
Full year 2025 revenue guidance is $423 to $435 million; adjusted EBITDA guidance remains $84 to $91 million.
Corcept reported first quarter 2025 revenue of $157.2 million, up from $146.8 million a year earlier, but net income fell to $20.5 million and diluted earnings per share fell to $0.17 from $0.25. The company reiterated its 2025 revenue guidance of $900 million to $950 million and said a specialty pharmacy vendor's capacity limits hurt first quarter results.
Revenue was $157.2 million versus $146.8 million in first quarter 2024.
Operating expenses rose to $153.8 million from $117.3 million, with selling, general and administrative expenses at $90.7 million versus $56.3 million.
2025 revenue guidance of $900 million to $950 million was reiterated.
Cash and investments were $570.8 million at March 31, 2025, down from $603.2 million at December 31, 2024.
V2X reported first-quarter 2025 results on May 5, 2025, with revenue of $1.02 billion, up slightly from $1.01 billion a year earlier, and net income of $8.1 million, up from $1.1 million. The company reaffirmed its 2025 guidance, including adjusted diluted EPS of $4.45 to $4.85. For shareholders, reported profit rose on modest revenue growth, and the unchanged guidance means no revision to the company's full-year outlook.
Revenue of $1.02 billion versus $1.01 billion in the first quarter of 2024
Net income of $8.1 million versus $1.1 million; GAAP diluted EPS of $0.25 versus $0.04
Adjusted diluted EPS of $0.98, up 9% year over year; adjusted EBITDA of $67.0 million, a 6.6% margin
2025 guidance reaffirmed: revenue of $4,375 million to $4,500 million and adjusted EBITDA of $305 million to $320 million
Realty Income reported first-quarter 2025 net income available to common stockholders of $249.8 million, or $0.28 per share, up from $129.7 million, or $0.16 per share, a year earlier, on total revenue of $1.38 billion versus $1.26 billion. The company lowered its 2025 net income per share guidance to $1.40-$1.46 from $1.52-$1.58, while its AFFO per share guidance of $4.22-$4.28 was unchanged.
Q1 2025 total revenue was $1,380.5 million, up from $1,260.5 million in Q1 2024.
Q1 2025 AFFO per diluted share rose 2.9% to $1.06 from $1.03.
2025 net income per share guidance was revised to $1.40-$1.46 from $1.52-$1.58, as issued February 24, 2025.
2025 AFFO per share guidance of $4.22-$4.28 was unchanged.
Upwork reported first-quarter 2025 revenue of $192.7 million, up 1% from a year earlier, and net income of $37.7 million, more than double the $18.4 million reported in the first quarter of 2024. The company reiterated its full-year 2025 revenue guidance of $740 million to $760 million and raised its full-year adjusted EBITDA guidance to $190 million to $200 million, which matters to shareholders because profit is growing faster than revenue.
Revenue was $192.7 million, up 1% from $190.9 million in Q1 2024.
Net income was $37.7 million, or $0.27 per diluted share, versus $18.4 million, or $0.13 per diluted share, a year earlier.
Adjusted EBITDA was $56.0 million, compared with $33.3 million in Q1 2024.
Full-year 2025 adjusted EBITDA guidance is $190 million to $200 million; Q2 2025 revenue guidance is $184 million to $189 million.
IAC Inc. (NASDAQ: IAC) reported first-quarter 2025 results on May 5, 2025. Revenue fell 9% to $570.5 million from $624.3 million, and the company swung to a net loss attributable to shareholders of $216.8 million, or $2.64 per diluted share, from net earnings of $45.0 million a year earlier, mainly because of a $324.3 million unrealized loss on its MGM Resorts stake. Operating income rose to $35.8 million from a $63.4 million loss, and the company reiterated its full-year 2025 guidance.
Net loss attributable to IAC shareholders of $216.8 million, or $2.64 per diluted share, versus net earnings of $45.0 million, or $0.51 per diluted share, in Q1 2024
Unrealized loss of $324.3 million on the MGM Resorts investment; IAC held 64.7 million MGM shares worth $2.1 billion as of May 2, 2025
Adjusted EBITDA of $50.9 million versus $5.5 million a year earlier; free cash flow was negative $4.6 million
Repurchased 4.5 million shares for $200 million between February 12 and May 2, 2025; 9.2 million shares remained under the 10 million share authorization approved March 16, 2025
Dorman Products reported first-quarter 2025 results for the quarter ended March 29, 2025, with net sales of $507.7 million, up 8.3% from a year earlier, and diluted EPS of $1.87, up 78%. The company reaffirmed its full-year 2025 guidance, which excludes the impact of U.S. tariffs, and management said the tariffs are expected to have a significant impact on the motor vehicle aftermarket.
Net sales were $507.7 million, up 8.3% from $468.7 million, led by Light Duty segment sales of $408.8 million, up 14%.
Diluted EPS was $1.87 versus $1.05; adjusted diluted EPS was $2.02 versus $1.31, up 54%.
Full-year 2025 guidance reaffirmed: net sales growth of 3% to 5%, diluted EPS of $7.00 to $7.30, excluding tariffs.
Operating cash flow was $51 million; the company repaid $20 million of debt and repurchased $12 million of shares.
Ichor Holdings reported first quarter 2025 revenue of $244.5 million, up from $201.4 million a year earlier, and a GAAP net loss of $4.6 million, or $(0.13) per diluted share, compared with a $9.0 million loss a year earlier. The company said policy uncertainty has led it to take a more conservative view of second-quarter demand, and it guided to second-quarter revenue of $225 million to $245 million.
Q1 2025 revenue was $244.5 million, compared with $233.3 million in Q4 2024 and $201.4 million in Q1 2024.
GAAP diluted EPS was $(0.13) for Q1 2025, versus $(0.30) in Q1 2024; non-GAAP diluted EPS was $0.12.
Q2 2025 outlook: revenue of $225 million to $245 million and GAAP diluted EPS of $(0.06) to $0.04.
Cash and cash equivalents were $109.3 million at March 28, 2025, with operating cash flow of $19.0 million in the quarter.
Sabra Health Care REIT reported first quarter 2025 net income of $40.3 million, or $0.17 per diluted share, up from $26.3 million, or $0.11, a year earlier. Total revenues rose to $183.5 million from $166.7 million, and the company reiterated its 2025 guidance. The results show year-over-year growth in both revenue and profit, with normalized FFO per diluted share up slightly to $0.35 from $0.34.
Net income was $40.3 million ($0.17 per diluted share) for Q1 2025, versus $26.3 million ($0.11) in Q1 2024.
Total revenues were $183.5 million, versus $166.7 million in Q1 2024.
FFO per diluted share was $0.36, versus $0.32; normalized FFO per diluted share was $0.35, versus $0.34.
Board declared a quarterly cash dividend of $0.30 per share, payable May 30, 2025, to holders of record as of May 16, 2025.
Adeia reported first quarter 2025 revenue of $87.7 million, up from $83.4 million a year earlier, and GAAP net income of $11.8 million, compared with $0.9 million in the prior-year quarter. The company reiterated its full-year 2025 revenue outlook of $390.0 million to $430.0 million, so shareholders have no new guidance change to weigh.
Q1 2025 revenue was $87.7 million, compared with $83.4 million in Q1 2024
GAAP diluted EPS was $0.10 versus $0.01 a year earlier; non-GAAP diluted EPS was $0.26
Cash from operations was $57.1 million, compared with $67.2 million in Q1 2024
2025 revenue outlook of $390.0 million to $430.0 million was reiterated
Inspire Medical Systems reported first quarter 2025 revenue of $201.3 million, up 23% from a year earlier, and diluted earnings of $0.10 per share compared with a loss of $0.34 per share in the prior-year quarter. The company maintained its full year 2025 revenue guidance of $940 million to $955 million and raised its diluted EPS guidance to $2.20 to $2.30 from $2.10 to $2.20.
Q1 2025 revenue was $201.3 million, up 23% from $164.0 million; U.S. revenue rose 24% to $193.6 million, while revenue outside the U.S. fell 6% to $7.7 million
Q1 2025 net income was $3.0 million, compared with a net loss of $10.0 million a year earlier; operating loss narrowed to $1.5 million from $15.2 million
Full year 2025 revenue guidance of $940 million to $955 million was maintained; diluted EPS guidance was raised to $2.20 to $2.30
Cash, cash equivalents and investments were $414.0 million at March 31, 2025, versus $516.5 million at December 31, 2024
Neurocrine Biosciences reported first-quarter 2025 total revenues of $572.6 million, up from $515.3 million a year earlier, while GAAP diluted earnings per share fell to $0.08 from $0.42. The company reaffirmed its full-year 2025 INGREZZA net sales guidance of $2.5 billion to $2.6 billion, but higher R&D spending and a $30.6 million unrealized loss on equity investments reduced profit.
INGREZZA first-quarter net product sales were $545.2 million, compared with $506.0 million a year earlier; CRENESSITY sales were $14.5 million.
GAAP net income was $7.9 million, versus $43.4 million in Q1 2024; non-GAAP net income was $71.5 million, versus $124.8 million.
Q1 2025 R&D expense includes $45 million of development milestones, mainly tied to starting the osavampator Phase 3 program in major depressive disorder.
Cash, cash equivalents and marketable securities totaled $1,758.8 million at March 31, 2025, and $150 million of a $500 million buyback had been repurchased by that date.
NAPCO reported fiscal third-quarter 2025 results for the three months ended March 31, 2025, with net sales down 10.8% year over year and net income down 23.3%. Recurring service revenue rose while equipment sales fell, and the board declared a $0.14 per share dividend, up from $0.125. The company also named Andrew Vuono as Chief Financial Officer, effective May 6, 2025, replacing Kevin Buchel in that role.
Net sales were $44.0 million, down 10.8%; equipment revenue fell 24.8% to $22.4 million while recurring service revenue rose 10.6% to $21.6 million
Net income was $10.1 million, down 23.3%; diluted EPS was $0.28 versus $0.36 a year earlier
Gross profit margin rose to 57.2% from 53.8%, and adjusted EBITDA was $13.2 million versus $15.6 million
Andrew Vuono becomes CFO effective May 6, 2025; Kevin Buchel remains President and Chief Operating Officer; dividend of $0.14 payable July 3, 2025 to holders of record June 12, 2025
International Bancshares Corporation reported first-quarter 2025 net income of about $96.9 million, or $1.56 per diluted share, versus about $97.3 million, or $1.56 per diluted share, a year earlier. Net income fell 0.5%, while diluted EPS was unchanged. Higher interest income was offset in part by higher deposit costs, and total assets rose to about $16.3 billion from $15.7 billion at December 31, 2024.
Q1 2025 net income: about $96.9 million, down from about $97.3 million in Q1 2024 (a 0.5% decrease)
Diluted EPS: $1.56 in both periods; basic EPS $1.56 versus $1.57
Net interest income was hurt by higher interest expense, mainly from higher rates paid on deposits; provision for credit loss expense decreased
Total assets about $16.3 billion at March 31, 2025, versus $15.7 billion at December 31, 2024; deposits about $12.5 billion versus $12.1 billion
onsemi reported first-quarter 2025 revenue of $1,445.7 million, down 22% from a year earlier and 16% from the prior quarter, and a GAAP net loss of $486.1 million, or $1.15 per diluted share, after $539.3 million in restructuring, asset impairments and other charges. For shareholders, the company guided second-quarter 2025 revenue to $1,400 million to $1,500 million and said it returned 66% of first-quarter free cash flow through share repurchases.
Revenue of $1,445.7 million, down 16% from Q4 2024 and 22% from Q1 2024
GAAP net loss attributable to ON Semiconductor of $486.1 million, or $(1.15) per diluted share; non-GAAP diluted EPS of $0.55
Restructuring, asset impairments and other charges, net of $539.3 million; GAAP operating margin of (39.7)%
Q2 2025 outlook: revenue of $1,400 million to $1,500 million and GAAP diluted EPS of $0.45 to $0.55
JBT Marel reported first quarter 2025 revenue of $854 million and orders of $916 million, but a $173 million net loss, driven largely by a $147 million non-cash pension settlement charge, weighed on results. The company suspended its full-year 2025 guidance and instead provided second quarter guidance, citing uncertainty from trade policies and tariffs.
Net loss $173 million, or $(3.35) per diluted share, including $147 million pension settlement charge; adjusted EPS $0.97 versus $1.11 in Q1 2024 as recast
Full-year 2025 guidance suspended; Q2 2025 guidance is revenue $885-$915 million and adjusted EPS $1.20-$1.40
Company continues to expect $35-$40 million in realized cost synergies for full-year 2025
TG Therapeutics reported first quarter 2025 total revenue of $120.9 million, up from $63.5 million a year earlier, and net income of $5.1 million compared with a net loss of $10.7 million. The company raised its full-year 2025 BRIUMVI U.S. net product revenue target to $560 million and its global revenue target to $575 million.
Total revenue of $120.9 million for the three months ended March 31, 2025, versus $63.5 million a year earlier
Net income of $5.1 million, or $0.03 per diluted share, versus a net loss of $10.7 million in the prior-year quarter
Full-year 2025 BRIUMVI U.S. net product revenue target raised to $560 million from $525 million; global revenue target raised to $575 million from $540 million
Total research and development expense rose to $46.4 million and selling, general and administrative expense to $50.3 million
Integra LifeSciences reported first-quarter 2025 results on May 5, 2025. Reported revenue rose 3.7% to $382.7 million, but organic revenue fell 3.5%, the GAAP net loss widened to $25.3 million, and adjusted earnings per diluted share fell to $0.41 from $0.55. The company reaffirmed its full-year revenue guidance but cut its full-year adjusted EPS guidance to $2.19 to $2.29, including an estimated $(0.22) per share impact from new tariffs.
Q1 revenue was $382.7 million, up 3.7% on a reported basis and down 3.5% on an organic basis.
GAAP net loss was $25.3 million, or $(0.33) per diluted share, versus a $3.3 million loss, or $(0.04), a year earlier.
Adjusted EPS was $0.41 versus $0.55; full-year adjusted EPS guidance was cut to $2.19 to $2.29.
Full-year 2025 revenue guidance of $1.650 billion to $1.715 billion was reaffirmed; second-quarter adjusted EPS is expected at $0.40 to $0.45.
Loews reported first-quarter 2025 net income of $370 million, or $1.74 per share, down from $457 million, or $2.05 per share, a year earlier. The decline was driven mainly by a $63 million pretax reserve charge at CNA, partly offset by higher earnings at Boardwalk Pipelines, and the company repurchased 5.1 million shares for $429 million since the end of 2024.
Net income attributable to Loews was $370 million, or $1.74 per share, versus $457 million, or $2.05 per share, in Q1 2024.
CNA net income fell to $252 million from $310 million; its combined ratio rose to 98.4% from 94.6%, including a $63 million pretax development charge largely tied to accident year 2024 commercial auto.
Boardwalk Pipelines net income rose to $152 million from $121 million, and its EBITDA increased to $346 million from $307 million.
Loews repurchased 5.1 million shares for $429 million since December 31, 2024; book value per share excluding AOCI was $89.74 on March 31, 2025, up from $88.18.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.